Sunstone Capital — Full Portfolio
66 tracked investments · listed companies and verified rows first
Amgen is an independent biotechnology company that uses science and technology, including machine learning and human genetic data, to research and develop treatments for serious diseases such as cancer, heart disease, asthma, and osteoporosis.
AI & Machine LearningBiotechHealthtechMedical DevicesThousand Oaks, US
William K. Bowes(Founder)George B. Rathmann(First CEO)David Piacquad(Executive Officer)Brian M. McNamee(Executive Officer)inRobert A. Bradway(Executive Officer, Director)David J. Scott(Executive Officer)
Co-investorsAsset Management CompanyBOMBoulder VenturesMayfield FundRidgeback Capital
DiogenX is a preclinical-stage biotech company developing biologic therapeutics aimed at restoring insulin-producing beta cells for people with Type 1 diabetes.
BiotechDeep TechDigital HealthHealthtechMarseille, FR
Benjamin Charles(Co-Founder & CEO)inPatrick Collombat(Co-Founder & Scientific Advisor)inJean-Pascal Tranié(Co-Founder)in
Co-investorsAdBio partnersRoche Venture FundBoehringer Ingelheim Venture FundJDRF T1D Fund
MinervaX is a biotech company developing prophylactic vaccines, with therapeutic focus areas including immunology and infectious disease.
BiotechHealthtech
PerBengt(CSO)
Co-investorsAdjuvant CapitalIndustrifondenOrbiMedPureos BioventuresSanofi VenturesEQT Life Sciences+2 more
Acarix provides diagnostic systems and supports investigator-initiated clinical trials and research projects to advance medical knowledge in cardiovascular disease assessment.
Digital HealthHealthtechMedical Devices
Claus Bo Vöge Christensen(Founder)Peter Samuelsen(Founder)
Co-investorsSEED Capital DenmarkSeventure Partners
Tula Tula Blankets manufactures hand-brushed and woven blankets using ethically sourced materials, produced in South Africa with a focus on fair labor practices and community empowerment in Southern Africa.
Circular EconomyConsumerDirect to ConsumerImpact & Social GoodSouth Africa, ZA
Co-investorsCraigie CapitalOctopus VenturesCrane Venture PartnersExperian VenturesOrange Digital VenturesSparkLabs Global Ventures+1 more
Alligator Bioscience AB is a biotechnology company whose shares are listed on NASDAQ Stockholm (Small Cap) under the ticker ATORX.
BiotechHealthtechLund, SE
Carl Borrebaeck(Director)in
BoardPeter Benson(Director)Mathias Uhlen(Director)Claes Ericsson(Director)Jacob Lindberg(Director)Kenth Petersson(Director)
Arcoma develops high-end radiology and X-ray imaging systems, integrating detectors and imaging software through partnerships with technology providers such as Canon Medical Systems and Varex.
Advanced ManufacturingHardwareHealthtechMedical DevicesVäxjö, SE
Mattias Leire(VD (CEO))inMattias Guldstrand(CTO)inGöran Edwall(Interim CFO)André Malmberg(COO)in
Co-investorsEiffel Investment Group
Ascelia Pharma is a biotech company developing and commercializing drugs for rare, orphan oncology-related conditions with unmet medical needs.
BiotechHealthtechMedical DevicesMalmö, SE
Magnus Corfitzen(Chief Executive Officer)inAndreas Norlin(Chief Scientific Officer)inJennie Wilborgsson(Chief Operating Officer)inAnton Hansson(Chief Financial Officer)in
Audibene sells hearing aids and related digital solutions for people with hearing loss through Germany's largest network of partnered acousticians.
Digital HealthHealthtechMedical DevicesBerlin, DE
Co-investorsActon CapitalHeartcore CapitalSTS Ventures GmbH
Blackwood Seven builds HamiltonAI, a Bayesian AI platform that links marketing and media investments to sales results to help marketers measure media effectiveness and optimize ROI.
AdTechAI & Machine LearningMarketing Tech
Co-investorsJolt CapitalSeed Capital Limited
Boozt is an online retailer offering fashion and lifestyle products to consumers, with a mobile app and delivery service.
ConsumerE-commerceRetail Tech
Peter G. Jørgensen(Founder)in
Co-investorsFriheden InvestHeartcore CapitalVerdane
Cantargia is a company listed on Nasdaq Stockholm (Small Cap).
BiotechHealthtech
Clinical-stage biopharmaceutical company developing RNA therapeutics for cardiac disease.
Co-investorsBioMedPartnerscoparionHadean VenturesInkefEQT Life SciencesFund+
New York, US
Suchit Dash(Executive Officer)Jonas Druppel(Founder)in
BoardDanny Rimer(Director)in
Co-investorsBalderton CapitalEniac VenturesGeneral CatalystRaineIndex VenturesLowercase Capital
Egalet develops medicines for people living with moderate to severe pain, including approved and licensed pain products.
BiotechHealthtechMedical DevicesWayne, US
BARBARA A. CARLIN(SENIOR VICE PRESIDENT AND CHIEF ACCOUNTING OFFICER)ROBERT S. RADIE(CHIEF EXECUTIVE OFFICER)MARK STROBECK(EXECUTIVE VICE PRESIDENT AND CHIEF OPERATING OFFICER)MEGAN TIMMINS(SENIOR VICE PRESIDENT AND GENERAL COUNSEL)PATRICK M. SHEA(SENIOR VICE PRESIDENT AND CHIEF COMMERCIAL OFFICER)Jeffrey M. Dayno(Chief Medical Officer)
Co-investorsAtlas Venture
Evolva (EvoNext Holdings SA / Evolva Holding AG) develops and markets flavour and fragrance products.
BiotechFoodTechNew Materials
Co-investorsVenturEastEntrepreneurs FundNice & Green
F2G develops medicines to treat serious fungal diseases where existing therapies have failed or are ineffective.
BiotechDigital HealthHealthtechMedical Devices
Co-investorsAdvent Life SciencesAisling CapitalAMR Action FundAstellas Venture Management LLCBrace PharmaSofinnova Partners+4 more
Damora Therapeutics is a biotechnology company developing subcutaneous biologics as targeted, disease-modifying treatments for patients with mutant calreticulin (mutCALR)-driven myeloproliferative neoplasms such as essential thrombocythemia and myelofibrosis.
BiotechMedical Devices
Jennifer Jarrett(Chief Executive Officer & Board Director)inSherwin Sattarzadeh(Chief Operating Officer)inBecker Hewes(Chief Medical Officer)Garrett Winslow(General Counsel)inJim Baker(Chief Corporate Affairs Officer)inBrian Burkavage(Senior Vice President, Finance)in
Co-investorsEIR VenturesHadean VenturesM VenturesSEED Capital DenmarkSeventure PartnersYsios Capital+3 more
GetYourGuide is a global online marketplace where travelers discover and book travel experiences such as tours, attractions, and activities in over 18,000 cities.
ConsumerMarketplacesTravel & Hospitality
JohannesTao
Co-investorsG SquaredView DifferentBattery VenturesBlue Pool CapitalBNP ParibasHeartcore Capital+8 more
Grandhood provides pension advisory and financial services in Denmark.
FintechDenmark, DK
Erik Frandsen(Kaptajn & Ejer)Morten Dyhrberg Wewer(Co-CEO)inAdam Ørskov(Co-CEO)inJens Kam(Founder)Jon Lieberkind(Founder)Mathias Bredkjær(Founder)
Co-investorsHeartcore CapitalSEED Capital DenmarkSeed Capital LimitedSpeedinvest
IOBiotech appears to be a biotech company focused on oncology, with a founder who has extensive experience in cancer drug development and clinical advancement from roles at Roche, Eli Lilly, and leading academic cancer centers.
BiotechMedical Devices
Dr. Dhingra
Co-investorsAvoro Capital AdvisorsEIR VenturesKurma PartnersPivotal Life SciencesRA CapitalSamsara BioCapital+4 more
JenaValve develops transcatheter aortic valve replacement systems to treat severe aortic regurgitation and aortic stenosis.
Digital HealthHealthtechMedical DevicesIrvine, US
Hans Figulla(Director)Markus FerrariVictoria Carr-Brendel(Executive Officer, Director)David Drachman(Executive Officer, Director)
BoardArnd Kaltofen(Director)inErik Amble(Director)
Co-investorsAndera PartnersBain Capital Life SciencesRosetta Capital Ltd.VI PartnersAtlas VentureGimv+5 more
Kontakt.io provides an AI-powered real-time location system and care operations platform for hospitals, combining Bluetooth LE devices, managed IoT infrastructure, and cloud analytics to optimize patient and staff safety, reduce length of stay, and streamline healthcare operations.
AI & Machine LearningHealthtechIoTSaaSNew York City, US
Tomasz Kolek(Executive Officer, Director)Szymon Niemczura(Executive Officer, Director)inPhilipp von Gilsa(CEO)in
BoardJan Habermann(Director)inMaximilian Niederhofer(Director)
Co-investorsHeartcore CapitalCredo VenturesGoldman Sachs
Kynexis is a clinical-stage biotech developing KYN-5356, an oral small-molecule KAT-II inhibitor targeting the kynurenine pathway to improve cognition in neurological diseases.
BiotechDeep TechHealthtech
Robert Schwarcz(Scientific Co-founder)Carol Tamminga(Scientific Co-founder & Chair of the SAB)Christer Köhler(Founding Director)inKees Been(Chief Executive Officer)inJens Wendland(Chief Medical Officer)inNeil Swami(Chief Business Officer)
Co-investorsYsios CapitalForbionNovartis Venture Fund
Lucira Health manufactures portable diagnostic devices that connect to smartphones to test bodily fluids for infectious diseases, enabling rapid results outside of clinical settings.
BiotechHealthtechMedical DevicesEmeryville, US
Debkishore Mitra(Founder)inJohn R. Waldeisen(Director)
BoardErik T. Engelson(Executive Officer, Director)Justin Butler(Director)Tuff Yen(Director)Steve Tablak(Director)
Co-investors11.2 CapitalForesite CapitalShangBay Capital LLCY CombinatorDCVC (Data Collective)DHVC+5 more
Mojiworks develops games that connect communities through social play on platforms like Discord, Reddit, and Snapchat.
AI & Machine LearningCreator EconomyGaming
Matthew Wiggins(CEO)in
Co-investorsBalderton CapitalHeartcore CapitalLifeline Ventures
Natural Cycles offers an FDA-cleared mobile app that uses a user's body temperature data and an algorithm to predict fertile windows for hormone-free birth control and pregnancy planning.
Digital HealthFemTechMedical Devices
Dr. Elina Berglund Scherwitzl(Co-founder and CEO)inRaoul Scherwitzl(Founder)inElina Berglund(Founder)Elina Berglund Scherwitzl(Founder)
Co-investorsBonnier CapitalHeadlineHeadline Growth Management, LLCHeartcore CapitalLauxera Capital PartnersBonnier Ventures+2 more
Neumirna develops miRNA-based therapies for neurological diseases such as epilepsy and Parkinson's.
BiotechLongevity
Co-investorsIaso VenturesInvivo Capital Partners
Obliquet develops therapeutics using an antibody platform called AbiProt to create novel medicines targeting disease-modifying human proteins, focusing on severe diseases with unmet clinical needs such as pain management.
AI & Machine LearningBiotechDigital HealthMedical DevicesStockholm, SE
OxThera develops a live biotherapeutic product based on oxalate-degrading bacteria to treat primary hyperoxaluria and other rare kidney diseases.
BiotechHealthtechMedical DevicesStockholm, SE
Elisabeth Lindner(Chief Operating Officer)Mats-Olof Wallin(Chief Financial Officer)Milt Allison
Co-investorsHealthCapYsios Capital
Peakon (Workday Peakon Employee Voice) is an AI-powered employee listening platform that collects and analyzes staff feedback to help organizations measure engagement, forecast turnover, and support leadership development and DEI efforts.
AI & Machine LearningHR TechSaaS
Christian Holm(Founder)Dan Rogers(Founder)Kasper Hulthin(Founder)Phil Chambers(Founder)
Co-investorsAtomicoBalderton CapitalEmblemMoonfire VenturesEQT VenturesHeartcore Capital+1 more
Prexton Therapeutics was a biopharmaceutical company developing novel therapies for Parkinson's disease, including its lead mGluR4 modulator candidate foliglurax.
BiotechHealthtechMedical DevicesCopenhagen, DK
Co-investorsCardinal PartnersM VenturesSeroba Life SciencesYsios CapitalForbion
Prezi offers an AI-powered presentation tool that generates fully designed decks from a prompt or an uploaded file (PPTX, PDF, DOCX), with conversational refinement and support for its zooming presentation format.
AI & Machine LearningFuture of WorkSaaSSan Francisco, US
Peter Halacsy(Founder)inPeter Arvai(Founder)inAdam Somlai-Fischer(Founder)inJim SzafranskiinAdam Somlai(Founder)
BoardChristian Lindegard Jepsen(Director)in
Co-investorsAccelHeartcore CapitalSpectrum Equity
Resalis Therapeutics develops antisense oligonucleotide therapies targeting microRNA pathways for metabolic disorders.
BiotechHealthtechLongevityMedical DevicesTurin, IT
Riccardo Panella(Chief Scientific Officer & Co-Founder)inSakari Kauppinen(Chief Technology Officer & Co-Founder)in
Co-investorsClaris VenturesItalian Angels for Growth
Rewind Therapeutics is a biotech company focused on neurodegeneration and neuroimmune diseases, with leadership and scientific advisory expertise in drug discovery, clinical development, and translational research for conditions like multiple sclerosis and Alzheimer's disease.
BiotechDeep TechDigital HealthHealthtechMedical DevicesLeuven, BE
Jim Van Heusden(Executive Chair)Irene Knuesel(Chief Scientific Officer)Christophe Van Vaeck(Chief Financial Officer)Ricardo Hermosilla(Head of Translational Medicine)Stephen Burbidge(VP Preclinical Drug Development)
Co-investorsBoehringer Ingelheim Venture FundPMVM Ventures
Step Pharma develops oral cancer drugs that inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1), with its lead therapeutic dencatistat in clinical development for lymphoma, solid tumors, and essential thrombocythaemia.
BiotechDeep TechMedical DevicesSaint-Genis-Pouilly, FR
Alain Fischer(Founding Scientist)
Co-investorsHadean VenturesKurma PartnersBpifrancePontifax Venture CapitalV-Bio Ventures
Synendos is a biotech company developing selective endocannabinoid reuptake inhibitors targeting the endocannabinoid system to treat neuropsychiatric disorders.
BiotechDeep TechDigital HealthMental HealthBasel, CH
Prof. Jürg Gertsch(Founder)Dr. Andrea Chicca(Co-Founder & Chief Executive Officer)Dr. Simon Russell(Co-Founder & Chief Commercial Officer)
Co-investorsKurma PartnersYsios CapitalHigh Tech Gruenderfonds
TargED is a biopharmaceutical company developing therapeutics for thrombotic disorders, spun out from University Medical Center Utrecht.
BiotechMedical DevicesUtrecht, NL
Coen Maas(Co-founder)inSteven de Maat(Chief Scientific Officer)inMarc van Moorsel(Director of Operations)inKristof Vercruysse(Chief Executive Officer)inRob Dekker(Vice President CMC)inFilip Van den Wyngaert(Vice President Asset Management)in
Co-investorsAndera PartnersBioGeneration VenturesCurie CapitalFund+Hadean VenturesInkef+1 more
Teitur Trophics is a biotech company developing therapies that target the sortilin family of receptors (SorCS-receptor biology) to activate the brain's natural survival pathways and preserve brain function.
BiotechDeep TechHealthtechLongevityAarhus, DK
Simon Mølgaard(Co-founder & CEO)inAnders Dalby(Co-founder)inMathias Ollendorff(Co-founder)inSimon Glerup(Co-founder)in
Co-investorsIndustrifondenP53 InvestInnovestorSound Bioventures
Tink operates a cloud-based open banking platform accessed through a single API, offering payment initiation and account data aggregation/enrichment services under its own PSD2 license.
Data & InfrastructureFintechSaaSStow, US
Daniel Kjellén(Founder)inThomas J. Chevalier(President)Daniel Kjellen(Founder)Fredrik Hedberg(Founder)
Co-investorsDawn CapitalFinTech VenturesHeartcore CapitalInsight PartnersOpera Tech VenturesABN AMRO Ventures+2 more
Traplight is a game development studio that creates games with user-generated content (UGC) features, working on its own original IPs as well as titles built with high-profile brand partners.
Gaming
Co-investorsHeartcore CapitalEQT VenturesKorea Investment PartnersPlay Ventures
VAXIMM is a clinical-stage biopharmaceutical company developing oral T-cell immunotherapies for cancer, based on technology invented at UC San Diego.
BiotechDigital HealthHealthtech
Andreas Niethammer(Founder & Chief Executive Officer)in
Zolar operates an online platform that connects homeowners in Germany with vetted regional installation companies for solar and clean-energy projects, including photovoltaic systems, balcony power plants, wallboxes, and solar storage.
CleantechEnergyMarketplaces
Alex Melzer(Founder)inAlex Melzer Gregor Loukidis(Founder)Gregor Loukidis(Founder)
Co-investorsEnergy Impact PartnersHeartcore CapitalInven CapitalPartech VenturesReventBNP Paribas+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Action PharmaAssertiotxEuro DiagnosticaFollicumForendo PharmaJurag SeparationNeumirnaNuevolutionOblique TherapeuticsPrecisenseResalisRewind TherapeuticsRigontecSantaris PharmaStipe TherapeuticsSvarlifescienceSymphogenTargEDZealand Pharma
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.












































.png)





















.jpg)







































































